Green Thumb Ended Its String of Profitable Quarters. Is the Stock a Buy?

Green Thumb Industries (GTBIF) reported its first quarterly loss since 2025, with a $0.02 per share loss in Q3 2026, despite an 11.3% year-over-year revenue increase to $324.4 million. The company continues to grow sales and maintain financial discipline, with $58 million in operational cash flow and share buybacks totaling $77.7 million. Green Thumb is expanding in high-growth states and remains a stable bet in the cannabis industry, with a lower debt-to-EBITDA ratio compared to peers.

Original reporting
Published Nov 8, 2026, 5:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 8, 2026, 5:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Green Thumb Ended Its String of Profitable Quarters. Is the Stock a Buy? — source image
Decision brief

The 30-second read

$GTBIFBearishLow
01

Why it matters

The earnings miss introduces downside risk, but the company's cash flow and expansion plans provide a longer‑term upside narrative.

02

Market read

Earnings release provides fresh data for traders; the loss may trigger short‑term sell pressure, while cash flow and expansion could attract longer‑term investors.

03

What to watch

Upcoming adult‑use legalization in Virginia and Texas could offset short‑term earnings weakness.

Relevance 4/10Novelty 4/10Timing: after‑hours release

Background

Green Thumb Industries (OTC: GTBIF) is a leading U.S. cannabis retailer that has historically been profitable. The Q3 2026 results mark a shift to a loss while revenue continues to grow.

Company-level read

Ticker impact

$GTBIFBearishHigh confidence
Context

Green Thumb Industries reported a Q3 loss of $0.02 per share and revenue of $324.4 million, the first quarterly loss since Q2 2025.

Expected impact

likely downward pressure as investors price the loss

Evidence & confidence

The loss is a new material fact; investors typically react negatively to earnings misses, even when cash flow remains positive.

Market effects

May weigh on other U.S. cannabis retailers as the sector tracks earnings trends.

Limited to U.S. OTC cannabis market.

Low global impact; primarily affects niche cannabis investors.

Counterpoint

Strong cash generation and expanding store footprint could support a bounce if the loss is seen as temporary.

Key entities

  • Green Thumb Industries

    OTC‑listed cannabis retailer reporting Q3 2026 results.

Related articles

Med

Green Thumb Industries Inc (GTBIF) (Q3 2026) Earnings Call Highlights: Revenue Climbs 11%

Green Thumb Industries (GTBIF) reported Q3 2026 revenue of $324M, up 11% YoY, with normalized EBITDA at $89M. Same-store sales grew 3%, and cash flow from operations was $58M. The company faces pricing pressure and regulatory uncertainty, with Q4 revenue expected to be flat. CEO Ben Kovler emphasized caution in capital allocation due to uncertainty. The company is expanding in markets like Virginia, Texas, and Florida, with plans for 3-5 Florida stores by year-end and 10+ in 2027.

$GTBIFMed

Green Thumb Industries Reports Third Quarter 2026 Results

Green Thumb Industries Inc. (GTBIF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Green Thumb Industries Reports Third Quarter 2026 Results CHICAGO and VANCOUVER, British Columbia, November 4, 2026 – Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis company with a portfolio of best

Med

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued?

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

$CURLFHighAI 9/10

The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up.

Curaleaf (CURLF) has proposed a $260M takeover of Aurora Cannabis (ACB), offering 0.3463 shares and $0.75 cash per share. Aurora, despite financial struggles, is attractive for its European market share. Green Thumb Industries (GTBIF), a profitable U.S. cannabis retailer, may also pursue acquisitions post-rescheduling, focusing on smaller, strategic deals.

$GTBIFMed

Green Thumb Amends RYTHM Notes and Warrants, Removes Ownership Cap; $72M Notes Affected

Green Thumb Industries (GTBIF) amended its secured convertible notes, pre-funded warrants, and shared services agreement with RYTHM to remove a 49.99% beneficial ownership cap. The amendment affects $72.0M of original principal and warrants for up to 9,731,638 shares, effective Oct 10, 2026. Green Thumb will consolidate RYTHM from that date, without intending to exercise the securities.